229 related articles for article (PubMed ID: 7949469)
1. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux.
Chan TC
Cancer Res; 1989 May; 49(10):2656-60. PubMed ID: 2713849
[TBL] [Abstract][Full Text] [Related]
5. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds.
Okazaki T; Kato Y; Mochizuki T; Tashima M; Sawada H; Uchino H
Exp Hematol; 1988 Jan; 16(1):42-8. PubMed ID: 2826200
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of N-linked glycosylation induces early apoptosis in human promyelocytic HL-60 cells.
PĂ©rez-Sala D; Mollinedo F
J Cell Physiol; 1995 Jun; 163(3):523-31. PubMed ID: 7775595
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
Bhalla K; Nayak R; Grant S
Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
Grant S; Bhalla K; Rauscher F; Cadman E
Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
[TBL] [Abstract][Full Text] [Related]
9. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
Vilpo JA; Vilpo LM
Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
Grant S; Turner A; Nelms P; Yanovich S
Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
[TBL] [Abstract][Full Text] [Related]
11. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine.
Gunji H; Kharbanda S; Kufe D
Cancer Res; 1991 Jan; 51(2):741-3. PubMed ID: 1985792
[TBL] [Abstract][Full Text] [Related]
12. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
Abe I; Saito S; Hori K; Suzuki M; Sato H
Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
[TBL] [Abstract][Full Text] [Related]
13. Regulation of jun-B gene expression by 1-beta-D-arabinofuranosyl-cytosine in human myeloid leukemia cells.
Datta R; Kharbanda S; Kufe D
Mol Pharmacol; 1990 Oct; 38(4):435-9. PubMed ID: 2122229
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation.
Hallahan DE; Virudachalam S; Schwartz JL; Panje N; Mustafi R; Weichselbaum RR
Radiat Res; 1992 Mar; 129(3):345-50. PubMed ID: 1542722
[TBL] [Abstract][Full Text] [Related]
15. cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway.
Rubin E; Kharbanda S; Gunji H; Weichselbaum R; Kufe D
Cancer Res; 1992 Feb; 52(4):878-82. PubMed ID: 1737349
[TBL] [Abstract][Full Text] [Related]
16. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
Gandhi V; Plunkett W
Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
Segal-Bendirdjian E; Jacquemin-Sablon A
Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
[TBL] [Abstract][Full Text] [Related]
18. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines.
Kees UR; Ford J; Dawson VM; Piall E; Aherne GW
Cancer Res; 1989 Jun; 49(11):3015-9. PubMed ID: 2720661
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor.
Ikemoto H; Tani E; Matsumoto T; Nakano A; Furuyama J
J Neurosurg; 1995 Dec; 83(6):1008-16. PubMed ID: 7490614
[TBL] [Abstract][Full Text] [Related]
20. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
Henschler R; Brennscheidt U; Mertelsmann R; Herrmann F
Mol Pharmacol; 1991 Feb; 39(2):171-6. PubMed ID: 1996082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]